Alternative splicing of other members of the Krüppel-like factor (KLF) gene family, including the KLF6 tumor suppressor and the KLF4 regulator of stem cell pluripotency, has been previously described and shown to result in the production of several isoforms with specific biological functions and biomarker value (22–25). This evidence concerns the gene KLF6 and neoplasm.